Antibody Drug Conjugate Development and Manufacture
Piramal
Quintiles Signs Exclusive Development Deal with Merck Days After $1B IPO
 |
Just days after raising more than $1B in its IPO, Quintiles announced Wednesday it signed a five-year clinical development agreement with Merck Serono. Related news |
News in brief
US CRO PRA is proposing to go public again, more than six years since it was taken private, according to a confidential draft registration statement submitted to the US SEC.
Proposed UK “animal research” labelling laws may backfire if improvements in culture-based toxicology testing continue, according to in vitro CRO Cyprotex.
BioDuro opened a new laboratory in Shanghai, China on Wednesday to offer a range of customized biopharma services for its Asia Pacific clients.
Outsourcing-Pharma.com presents its latest round-up of the movers and shakers in the pharma service industry, including news from Theorem and Symbiosis.
Global Industry News
UK Animal Research Labelling Plan Must Not Put Patients Off Treatment, Says ABPI from in-PharmaTechnologist.com
New UK proposals to label all drugs as “produced as a result of research on animals” have met with muted response from pharmaceutical industry group, the ABPI.
Pfizer Puts Lipitor Site Up For Sale as Patent Expiration Causes Over-Capacity from in-PharmaTechnologist.com
Lower sales of off-patent former blockbuster Lipitor have prompted Pfizer to try and sell off its third Irish API plant in as many years.
US House Committee Advances Track-and-Trace Legislation from in-PharmaTechnologist.com
The US House Energy & Commerce Committee on Wednesday advanced a bill to further secure the US prescription drug supply chain, though it stops short of mandating unit-level, electronic tracking and tracing of drugs.
Ranbaxy Pleads Guilty to Manufacturing Adulterated Drugs from in-PharmaTechnologist.com
In the largest US generic drug safety settlement ever, Ranbaxy USA has agreed to pay $500m after pleading guilty to manufacturing and distributing adulterated drugs, according to the US Justice Department settlement agreement .
Hot topics
Spotlight
  Executives Raise Questions on Clinical Trial Sponsors’ Oversight of CROsTension between clinical trial sponsors and CROs in terms of CRO oversight may not be relieved any... |